These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24356705)

  • 21. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in the eradication rates of Helicobacter pylori infection for eleven years.
    Yoon JH; Baik GH; Sohn KM; Kim DY; Kim YS; Suk KT; Kim JB; Kim DJ; Kim JB; Shin WG; Kim HY; Baik IH; Jang HJ
    World J Gastroenterol; 2012 Dec; 18(45):6628-34. PubMed ID: 23236238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
    Sierra F; Forero JD; Rey M; Botero ML; Cárdenas A
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1165-71. PubMed ID: 23656465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
    Sereni G; Azzolini F; Camellini L; Formisano D; Decembrino F; Iori V; Tioli C; Cavina M; Di Mario F; Bedogni G; Sassatelli R
    World J Gastroenterol; 2012 Sep; 18(33):4542-8. PubMed ID: 22969227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
    Kawai T; Yamagishi T; Yagi K; Kataoka M; Kawakami K; Sofuni A; Itoi T; Sakai Y; Moriyasu F; Osaka Y; Takagi Y; Aoki T; Rimbara E; Noguchi N; Sasatsu M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S171-4. PubMed ID: 19120893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
    Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS
    J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: result of the HPFEZ randomised study.
    Lahbabi M; Alaoui S; El Rhazi K; El Abkari M; Nejjari C; Amarti A; Bennani B; Mahmoud M; Ibrahimi A; Benajah DA
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):416-21. PubMed ID: 23168228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
    Kato S; Konno M; Maisawa S; Tajiri H; Yoshimura N; Shimizu T; Toyoda S; Nakayama Y; Iinuma K
    J Gastroenterol; 2004 Sep; 39(9):838-43. PubMed ID: 15565402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
    Sivri B; Simsek I; Hulagu S; Kadayifci A; Tozun N; Akarsu M; Uraz S; Savas MC; Koruk M; Bozbas A
    Curr Med Res Opin; 2004 Aug; 20(8):1301-7. PubMed ID: 15324533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
    Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
    Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
    Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
    Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.